A human tumor necrosis factor (TNF) alpha mutant that binds exclusively to the p55 TNF receptor produces toxicity in the baboon.
A number of recent studies have demonstrated that cellular responses to tumor necrosis factor (TNF) mediated by the p55 and the p75 TNF receptors are distinct. To evaluate the relative in vivo toxicities of wild-type TNF alpha (wtTNF alpha) and a novel p55 TNF selective receptor agonist, healthy, anesthetized baboons (Papio sp.) were infused with a near-lethal dose of either wtTNF alpha or a TNF alpha double mutant (dmTNF alpha) that binds specifically to the p55, but not to the p75, TNF receptor. Both wtTNF alpha and dmTNF alpha produced comparable acute hypotension, tachycardia, increased plasma lactate, and organ dysfunction in Papio. However, administration of wtTNF alpha produced a marked granulocytosis and loss of granulocyte TNF receptors, whereas little if any changes in neutrophil number or cell surface TNF receptor density were seen after dmTNF alpha mutant administration. Infusion of dmTNF alpha resulted in a plasma endogenous TNF alpha response that peaked after 90-120 min. We conclude that selective p55 TNF receptor activation is associated with early hemodynamic changes and the autocrine release of endogenous TNF alpha. Significant systemic toxicity results from p55 TNF receptor activation, but the role of the p75 TNF receptor in systemic TNF toxicity requires further study.
Van Zee
K J
KJ
Department of Surgery, Cornell University Medical College, New York 10021.
Stackpole
S A
SA
Montegut
W J
WJ
Rogy
M A
MA
Calvano
S E
SE
Hsu
K C
KC
Chao
M
M
Meschter
C L
CL
Loetscher
H
H
Stüber
D
D
D000311:Adrenal Glands / Q000187:drug effects / Q000473:pathology; D000818:Animals; D001667:Binding, Competitive; D005260:Female; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D008099:Liver / Q000187:drug effects / Q000473:pathology; D008297:Male; D009154:Mutation; D010215:Papio; D018124:Receptors, Tumor Necrosis Factor / Q000378:metabolism*; D013154:Spleen / Q000187:drug effects / Q000473:pathology; D014409:Tumor Necrosis Factor-alpha / Q000235:genetics / Q000493:pharmacokinetics / Q000633:toxicity*
D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha